Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-29

FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for alprazolam from Sandoz Inc under an Abbreviated New Drug Application, resulting in an approved addition or modificat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)